Switch-Maintenance Gemcitabine After First-Line Chemotherapy In Patients With Malignant Pleural Mesothelioma
NCT05660616
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Malignant Pleural Mesothelioma
Interventions
DRUG:
Gemcitabine
OTHER:
supportive care
Sponsor
Ain Shams University